Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone

J. M. Hermens, J. M. Ebertz, Jon Hanifin, C. A. Hirshman

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Human leukocytes and skin mast cell preparations were incubated with morphine sulfate in concentrations ranging from 1.5 x 10-5 M to 4.5 x 10-3 M. Skin mast cells also were incubated with oxymorphone and fentanyl in the same concentrations. Human leukocytes did not release histamine in response to any concentration of morphine. In skin mast cells, histamine release by morphine first was detected at 1.5 x 10-4 M. Histamine release further increased at 5.0 x 10-4 M with no incremental increase at higher concentrations. Oxymorphone and fentanyl failed to release histamine at any concentration. Histamine release by morphine required calcium but was not influenced by changes in the 1-4 mM range. Skin mast cell preparations were pretreated for 30 min in naloxone 5 x 10-4 M and then morphine 5 x 10-4 M was added for 30 min without removing naloxone. Naloxone neither released histamine nor inhibited morphine-induced histamine release. The release of histamine by morphine but not equimolar concentrations of fentanyl and oxymorphone indicates that histamine release by narcotics is not a nonspecific effect of high drug concentration. The failure of naloxone to inhibit morphine-induced histamine release suggests that histamine release by morphine is not dependent on opiate receptor binding or activation. These results indicate that this human mast cell preparation will be useful in further understanding the mechanism of histamine release induced by morphine and other agents.

Original languageEnglish (US)
Pages (from-to)124-129
Number of pages6
JournalAnesthesiology
Volume62
Issue number2
StatePublished - 1985

Fingerprint

Oxymorphone
Histamine Release
Fentanyl
Mast Cells
Morphine
Skin
Naloxone
Leukocytes
Narcotics
Opioid Receptors
Histamine

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. / Hermens, J. M.; Ebertz, J. M.; Hanifin, Jon; Hirshman, C. A.

In: Anesthesiology, Vol. 62, No. 2, 1985, p. 124-129.

Research output: Contribution to journalArticle

Hermens, J. M. ; Ebertz, J. M. ; Hanifin, Jon ; Hirshman, C. A. / Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone. In: Anesthesiology. 1985 ; Vol. 62, No. 2. pp. 124-129.
@article{59dafdacfa5e41009f0bb7355b9b05b9,
title = "Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone",
abstract = "Human leukocytes and skin mast cell preparations were incubated with morphine sulfate in concentrations ranging from 1.5 x 10-5 M to 4.5 x 10-3 M. Skin mast cells also were incubated with oxymorphone and fentanyl in the same concentrations. Human leukocytes did not release histamine in response to any concentration of morphine. In skin mast cells, histamine release by morphine first was detected at 1.5 x 10-4 M. Histamine release further increased at 5.0 x 10-4 M with no incremental increase at higher concentrations. Oxymorphone and fentanyl failed to release histamine at any concentration. Histamine release by morphine required calcium but was not influenced by changes in the 1-4 mM range. Skin mast cell preparations were pretreated for 30 min in naloxone 5 x 10-4 M and then morphine 5 x 10-4 M was added for 30 min without removing naloxone. Naloxone neither released histamine nor inhibited morphine-induced histamine release. The release of histamine by morphine but not equimolar concentrations of fentanyl and oxymorphone indicates that histamine release by narcotics is not a nonspecific effect of high drug concentration. The failure of naloxone to inhibit morphine-induced histamine release suggests that histamine release by morphine is not dependent on opiate receptor binding or activation. These results indicate that this human mast cell preparation will be useful in further understanding the mechanism of histamine release induced by morphine and other agents.",
author = "Hermens, {J. M.} and Ebertz, {J. M.} and Jon Hanifin and Hirshman, {C. A.}",
year = "1985",
language = "English (US)",
volume = "62",
pages = "124--129",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone

AU - Hermens, J. M.

AU - Ebertz, J. M.

AU - Hanifin, Jon

AU - Hirshman, C. A.

PY - 1985

Y1 - 1985

N2 - Human leukocytes and skin mast cell preparations were incubated with morphine sulfate in concentrations ranging from 1.5 x 10-5 M to 4.5 x 10-3 M. Skin mast cells also were incubated with oxymorphone and fentanyl in the same concentrations. Human leukocytes did not release histamine in response to any concentration of morphine. In skin mast cells, histamine release by morphine first was detected at 1.5 x 10-4 M. Histamine release further increased at 5.0 x 10-4 M with no incremental increase at higher concentrations. Oxymorphone and fentanyl failed to release histamine at any concentration. Histamine release by morphine required calcium but was not influenced by changes in the 1-4 mM range. Skin mast cell preparations were pretreated for 30 min in naloxone 5 x 10-4 M and then morphine 5 x 10-4 M was added for 30 min without removing naloxone. Naloxone neither released histamine nor inhibited morphine-induced histamine release. The release of histamine by morphine but not equimolar concentrations of fentanyl and oxymorphone indicates that histamine release by narcotics is not a nonspecific effect of high drug concentration. The failure of naloxone to inhibit morphine-induced histamine release suggests that histamine release by morphine is not dependent on opiate receptor binding or activation. These results indicate that this human mast cell preparation will be useful in further understanding the mechanism of histamine release induced by morphine and other agents.

AB - Human leukocytes and skin mast cell preparations were incubated with morphine sulfate in concentrations ranging from 1.5 x 10-5 M to 4.5 x 10-3 M. Skin mast cells also were incubated with oxymorphone and fentanyl in the same concentrations. Human leukocytes did not release histamine in response to any concentration of morphine. In skin mast cells, histamine release by morphine first was detected at 1.5 x 10-4 M. Histamine release further increased at 5.0 x 10-4 M with no incremental increase at higher concentrations. Oxymorphone and fentanyl failed to release histamine at any concentration. Histamine release by morphine required calcium but was not influenced by changes in the 1-4 mM range. Skin mast cell preparations were pretreated for 30 min in naloxone 5 x 10-4 M and then morphine 5 x 10-4 M was added for 30 min without removing naloxone. Naloxone neither released histamine nor inhibited morphine-induced histamine release. The release of histamine by morphine but not equimolar concentrations of fentanyl and oxymorphone indicates that histamine release by narcotics is not a nonspecific effect of high drug concentration. The failure of naloxone to inhibit morphine-induced histamine release suggests that histamine release by morphine is not dependent on opiate receptor binding or activation. These results indicate that this human mast cell preparation will be useful in further understanding the mechanism of histamine release induced by morphine and other agents.

UR - http://www.scopus.com/inward/record.url?scp=0021971485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021971485&partnerID=8YFLogxK

M3 - Article

C2 - 2578752

AN - SCOPUS:0021971485

VL - 62

SP - 124

EP - 129

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 2

ER -